Agilent Technologies, Inc. (NYSE:A) Stock Position Lifted by AE Wealth Management LLC

AE Wealth Management LLC increased its position in Agilent Technologies, Inc. (NYSE:A) by 11.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 179,367 shares of the medical research company’s stock after buying an additional 19,102 shares during the quarter. AE Wealth Management LLC owned about 0.06% of Agilent Technologies worth $23,251,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Livelsberger Financial Advisory acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at $26,000. Crewe Advisors LLC lifted its holdings in shares of Agilent Technologies by 114.8% in the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after buying an additional 101 shares during the period. Ridgewood Investments LLC acquired a new stake in shares of Agilent Technologies in the second quarter valued at $29,000. Rise Advisors LLC lifted its holdings in shares of Agilent Technologies by 527.8% in the first quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock valued at $33,000 after buying an additional 190 shares during the period. Finally, YHB Investment Advisors Inc. acquired a new stake in shares of Agilent Technologies in the first quarter valued at $34,000. Institutional investors and hedge funds own 87.42% of the company’s stock.

Insider Buying and Selling at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction on Friday, July 26th. The stock was sold at an average price of $140.00, for a total transaction of $274,120.00. Following the completion of the transaction, the chief executive officer now directly owns 26,076 shares of the company’s stock, valued at approximately $3,650,640. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.33% of the company’s stock.

Agilent Technologies Stock Up 2.1 %

NYSE:A opened at $141.95 on Friday. Agilent Technologies, Inc. has a 1 year low of $96.80 and a 1 year high of $155.35. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. The stock has a market cap of $41.42 billion, a price-to-earnings ratio of 33.56, a PEG ratio of 6.43 and a beta of 1.05. The stock has a 50-day moving average price of $137.72 and a two-hundred day moving average price of $139.27.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.26 by $0.06. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.56 billion. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The business’s quarterly revenue was down 5.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.43 earnings per share. As a group, equities analysts expect that Agilent Technologies, Inc. will post 5.24 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st will be given a dividend of $0.236 per share. This represents a $0.94 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date is Tuesday, October 1st. Agilent Technologies’s dividend payout ratio is currently 22.22%.

Analyst Ratings Changes

A has been the subject of several research analyst reports. Bank of America upped their price objective on Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. Evercore ISI upped their target price on Agilent Technologies from $130.00 to $135.00 and gave the company an “in-line” rating in a report on Thursday, August 22nd. Wells Fargo & Company began coverage on Agilent Technologies in a report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 target price for the company. Barclays upped their target price on Agilent Technologies from $125.00 to $135.00 and gave the company an “underweight” rating in a report on Friday, August 23rd. Finally, Citigroup upped their target price on Agilent Technologies from $150.00 to $165.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have given a buy rating to the company. According to MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and an average target price of $141.60.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.